MaxArc Global Health Impact Platform

Authorized Funder / CCM Review Room

FOR GLOBAL FUND / CCM / AUTHORIZED PARTNER REVIEW ONLY
Authorized review · Evidence packages · Human-approved · Demonstration only

A controlled review room for authorized funders, CCMs, ministries, and auditors.

A controlled view of platform capabilities, evidence, readiness, safeguards, and limitations. This is a review and demonstration environment — not a public evidence repository, official grant submission, production certification, or replacement for authorized investigative or regulatory processes. Capability claims link to evidence; unverified evidence stays labeled; incomplete evidence blocks approval; expired or superseded packages are not current. AI is assistive only and never approves a package, certifies readiness or grant compliance, verifies evidence without human review, or authorizes export.

You are viewing the Authorized Funder / CCM Review Room Dashboard — Synthetic non-identifiable demonstration data
Permitted use: This review room and its packages are provided for authorized review only. No anonymous or public access is implied. Unauthorized copying, redistribution, derivative or commercial use, and any representation of these materials as formal approval, production certification, grant compliance, or an official submission are prohibited. Access is limited to authorized roles under minimum-necessary access, is time-bound, and is revocable. Official grant submission remains a separate authorized process.
Confidentiality posture: Review packages are for authorized review only; no anonymous or public access is implied. Demonstration material is never represented as production certification. Capability claims link to evidence, unverified evidence stays labeled, incomplete evidence blocks final approval, and expired or superseded packages are not treated as current. Confidential materials require authorized roles and minimum-necessary access; patient identity, precise location, secrets, credentials, and restricted operational data are never exposed. Downloads or exports require explicit eligibility and authorization. Reviewer questions and decisions are attributable and auditable, sensitive packages may require second review, approvals are time-bound and revocable, and package history is never silently rewritten or deleted.
Evidence posture: Every capability claim references source-module evidence identifying source, status, reviewer, and audit reference. Screenshots and demonstrations are labeled with capture status and date. Unsupported claims stay blocked or incomplete, conflicting evidence remains visible, and evidence verification requires authorized human review. Review packages retain version history, superseded packages link to their replacement, package status never overrides source-module records, and evidence-room approval is not deployment authorization.
Total packages 6

In review room

Active packages 5

Current, not superseded

Pending authorization 1

Awaiting approval

Approved packages 3

Time-bound & revocable

Blocked packages 1

Evidence/dependency held

Expired / superseded 1

Not current

Modules represented 9

Across platform

Countries represented 2

Synthetic

Programs represented 3

HIV / TB / Malaria

Evidence completeness 90%

Present evidence

Verified evidence 7

Human-reviewed

Unverified evidence 3

Labeled, not final

Conflicting evidence 1

Kept visible

Open reviewer questions 2

Attributable

Unresolved limitations 5

Never removed

Deployment blockers 2

Readiness dependencies

Privacy-restricted 2

Minimum-necessary

Second-review queue 2

Sensitive packages

Expiration risk 0

Approvals <30d

Capability→evidence 100%

Claims linked

Unsupported claims 1

Blocked/incomplete

Audit completeness 100%

Package audit refs

Review packages

Each package is for authorized review only, is time-bound and revocable, and links capability claims to source-module evidence. Incomplete evidence blocks final approval; expired or superseded packages are not treated as current. *Export/download requires explicit eligibility and authorization.

PackageReviewer / classificationCoverageEvidenceStatus
Executive Capability Overview (synthetic demonstration)
PKG-EXEC-001 · v1.2
 global-fund-style-reviewer
confidential-authorized-review
 7 modules
CT-ANDT, CT-BENV · HIV, TB, Malaria
 verified
100% complete
 approved
expires 2026-10-01 · export: not eligible
Accountability & Anti-Misuse Overview (synthetic demonstration)
PKG-FUND-002 · v1.0
 auditor-inspector
confidential-authorized-review
 3 modules
CT-ANDT · HIV
 partially verified
75% complete
 pending authorization 2nd review
expires 2026-09-15 · export: not eligible
Laboratory & Continuity Overview (synthetic demonstration)
PKG-LAB-003 · v1.1
 ministry
confidential-restricted-privacy
 2 modules
CT-BENV · TB
 verified
90% complete
 approved 2nd review privacy
expires 2026-11-01 · export: not eligible
Asset & Program-Performance Overview (superseded synthetic demonstration)
PKG-CONT-004 · v1.0 · replaced by PKG-PERF-006
 ministry
confidential-authorized-review
 2 modules
CT-ANDT · TB, Malaria
 unverified
60% complete
 expired
expires 2026-07-01 · export: not eligible
AI Safeguards & Restricted-Locator Governance Overview (synthetic demonstration)
PKG-LOCATOR-005 · v0.9
 auditor-inspector
confidential-restricted-privacy
 2 modules
CT-ANDT, CT-BENV · HIV, TB
 conflicting
50% complete
 blocked 2nd review privacy
expires 2026-09-30 · export: not eligible
Asset & Program-Performance Overview (current synthetic demonstration)
PKG-PERF-006 · v2.0 · supersedes PKG-CONT-004
 ministry
confidential-authorized-review
 2 modules
CT-ANDT · TB, Malaria
 verified
95% complete
 approved
expires 2026-12-01 · export: eligible*

Capability-to-evidence coverage

Every capability claim references source-module evidence identifying source, status, reviewer, and audit reference. Unsupported claims stay blocked or incomplete; conflicting evidence remains visible. Package status never overrides source-module records.

Capability claimEvidenceVerificationSupport
Executive, operations, and oversight dashboards summarize impact across modules
CAP-001 · ai-intelligence
 EVD-RR-001 verified supported
Fund accountability flags misuse, diversion, and duplicate disbursement for human review
CAP-002 · fund-accountability
 EVD-RR-002 verified supported
Asset management tracks custody, transfers, and diversion risk with audit trail
CAP-003 · asset-management
 EVD-RR-003 partially verified supported
Laboratory results reach the ordering clinician with turnaround tracking
CAP-004 · lab-operations
 EVD-RR-004 verified supported
Patient continuity tracks follow-up and referral without exposing patient identity
CAP-005 · patient-continuity
 EVD-RR-005 verified supported
Program performance compares targets to results with data-quality and verification controls
CAP-006 · program-performance
 EVD-RR-006 verified supported
Restricted patient locator restricts search to authorized, consented, lawful requests with break-glass audit
CAP-007 · restricted-patient-locator
 EVD-RR-007 conflicting unsupported / blocked
package claim conflicts with source-module evidence; remains visible and blocked
AI surfaces anomalies and readiness signals but never approves, certifies, or discloses autonomously
CAP-008 · ai-intelligence
 EVD-RR-008 verified supported
Country rollout assesses readiness and controlled offline operation before activation
CAP-009 · country-rollout
 EVD-RR-009 verified supported

Review-package overviews

Executive capability, accountability & anti-misuse, commodity & logistics, laboratory & continuity, asset & program-performance, AI safeguards, country rollout & offline readiness, and evidence & limitations overviews — all clearly labeled as synthetic demonstration material.

Executive Capability Overview (synthetic demonstration)

Give authorized funders and CCM members a controlled overview of platform capabilities, safeguards, and limitations

View: executive-capability-overview · reviewer: global-fund-style-reviewer · approved

Modules: fund-accountability, stockpile-logistics, lab-operations, asset-management, program-performance, ai-intelligence, country-rollout

Capability claims: CAP-001, CAP-002, CAP-008 · evidence: EVD-RR-001, EVD-RR-002, EVD-RR-008

Synthetic demonstration material · not production certification · export: not eligible

Accountability & Anti-Misuse Overview (synthetic demonstration)

Demonstrate fund-accountability and anti-misuse safeguards to authorized auditors

View: accountability-anti-misuse-overview · reviewer: auditor-inspector · pending authorization

Modules: fund-accountability, asset-management, program-performance

Capability claims: CAP-002, CAP-003 · evidence: EVD-RR-002, EVD-RR-003

Synthetic demonstration material · not production certification · export: not eligible

Laboratory & Continuity Overview (synthetic demonstration)

Demonstrate lab-to-doctor and patient-continuity workflows with privacy controls

View: laboratory-continuity-overview · reviewer: ministry · approved

Modules: lab-operations, patient-continuity

Capability claims: CAP-004, CAP-005 · evidence: EVD-RR-004, EVD-RR-005

Synthetic demonstration material · not production certification · export: not eligible

Asset & Program-Performance Overview (superseded synthetic demonstration)

Earlier demonstration of asset and program-performance accountability; superseded

View: asset-program-performance-overview · reviewer: ministry · expired

Modules: asset-management, program-performance

Capability claims: CAP-003, CAP-006 · evidence: EVD-RR-003, EVD-RR-006

Synthetic demonstration material · not production certification · export: not eligible

AI Safeguards & Restricted-Locator Governance Overview (synthetic demonstration)

Demonstrate AI safeguards and restricted-locator governance to authorized oversight

View: ai-safeguards-overview · reviewer: auditor-inspector · blocked

Modules: ai-intelligence, restricted-patient-locator

Capability claims: CAP-007, CAP-008 · evidence: EVD-RR-007, EVD-RR-008

Synthetic demonstration material · not production certification · export: not eligible

Asset & Program-Performance Overview (current synthetic demonstration)

Current demonstration of asset and program-performance accountability, replacing PKG-CONT-004

View: asset-program-performance-overview · reviewer: ministry · approved

Modules: asset-management, program-performance

Capability claims: CAP-003, CAP-006 · evidence: EVD-RR-003, EVD-RR-006

Synthetic demonstration material · not production certification · export: eligible with authorization*

Evidence & verification

  • EVD-RR-001 — dashboard-demonstration (ai-intelligence) verified captured 2026-06-30
  • EVD-RR-002 — route-payload (fund-accountability) verified captured 2026-06-30
  • EVD-RR-003 — route-payload (asset-management) partially verified captured 2026-06-29
  • EVD-RR-004 — route-payload (lab-operations) verified captured 2026-06-28
  • EVD-RR-005 — aggregate-demonstration (patient-continuity) verified captured 2026-06-28
  • EVD-RR-006 — route-payload (program-performance) verified captured 2026-06-27
  • EVD-RR-007 — governance-attestation (restricted-patient-locator) conflicting pending conflicts with source
  • EVD-RR-008 — policy-attestation (ai-intelligence) verified captured 2026-06-30
  • EVD-RR-009 — route-payload (country-rollout) verified captured 2026-07-05
  • EVD-RR-MISSING-010 — physical-verification-record (asset-management) unverified missing missing

Open reviewer questions

  • Q-001 — Can the anti-diversion control demonstrate second-review separation of duties? open
    PKG-FUND-002 · asked by auditor-inspector
  • Q-002 — Why does the asset value reconciliation differ from the current package? resolved
    PKG-CONT-004 · asked by ministry
  • Q-003 — Package claim states locator search is broadly available; source module restricts it. Please reconcile. open
    PKG-LOCATOR-005 · asked by auditor-inspector · high

Unresolved limitations (never removed)

  • LIM-001 — All figures are synthetic demonstration data, not production results informational
    PKG-EXEC-001 · visible: yes
  • LIM-002 — One evidence item pending verification; approval blocked until complete material
    PKG-FUND-002 · visible: yes
  • LIM-003 — Patient-level detail excluded; only aggregate synthetic demonstration shown informational
    PKG-LAB-003 · visible: yes
  • LIM-004 — Country readiness dependency outstanding for one wave material
    PKG-PERF-006 · visible: yes
  • LIM-005 — Contradictory evidence between package claim and source module; claim unsupported critical
    PKG-LOCATOR-005 · visible: yes

Readiness dependencies / deployment blockers

  • DEP-001 — country-readiness sign-off for wave-2 countries outstanding
    PKG-EXEC-001 · source: country-rollout · blocks deployment: yes
  • DEP-002 — restricted-locator governance sign-off outstanding
    PKG-LOCATOR-005 · source: restricted-patient-locator · blocks deployment: yes

Authorizations (time-bound, revocable)

  • AZN-001 — global-fund-style-reviewer active
    PKG-EXEC-001 · granted by review-room-authority · expires 2026-10-01T00:00:00Z
  • AZN-002 — auditor-inspector active
    PKG-FUND-002 · granted by review-room-authority · expires 2026-09-15T00:00:00Z
  • AZN-003 — ministry expired
    PKG-CONT-004 · granted by review-room-authority · expires 2026-07-01T00:00:00Z
  • AZN-004 — auditor-inspector revoked
    PKG-LOCATOR-005 · granted by review-room-authority · expires 2026-09-30T00:00:00Z · reviewer role change

Privacy restrictions

  • patient-continuity — no patient identity, no precise location, minimum-necessary aggregate only enforced
  • restricted-patient-locator — no locator disclosure; governance attestations only, authorized reviewers only enforced
  • fund-accountability — financial detail restricted; no secrets or credentials exposed enforced
  • all — no secrets, credentials, or restricted operational data in any package or export enforced

Package status by reviewer type

  • global-fund-style-reviewer 1 (1 approved / 0 pending / 0 blocked / 0 expired)
  • auditor-inspector 2 (0 approved / 1 pending / 1 blocked / 0 expired)
  • ministry 3 (2 approved / 0 pending / 0 blocked / 1 expired)

By approval status

  • approved 3
  • pending-authorization 1
  • expired 1
  • blocked 1

By evidence verification

  • verified 7
  • partially-verified 1
  • conflicting 1
  • unverified 1

AI posture — assistive only, non-autonomous

AI assists with

  • summarize authorized review materials
  • map capability claims to evidence
  • identify missing evidence
  • detect contradictions between package claims and source modules
  • prioritize reviewer questions
  • flag expired or superseded materials
  • identify unresolved deployment dependencies
  • compare country readiness against claimed rollout scope
  • support authorized reviewer search and triage

AI must never

  • autonomously approve a package
  • certify production readiness
  • certify grant compliance
  • represent evidence as verified without human review
  • disclose restricted or patient-related information
  • remove limitations or unresolved questions
  • suppress contradictory evidence
  • authorize download, export, or redistribution
  • alter source-module records
  • bypass authorization, confidentiality, second review, or audit controls

AI is assistive only. It summarizes authorized materials, maps claims to evidence, identifies missing evidence, detects contradictions with source modules, prioritizes reviewer questions, and flags expired or superseded materials, but it never approves a package, certifies production readiness or grant compliance, represents evidence as verified without human review, discloses restricted information, removes limitations, suppresses contradictory evidence, authorizes export, alters source-module records, or bypasses authorization, confidentiality, second review, or audit controls.

Runtime boundary & linkage